Matter Number: 1510236 Related Federal Register Notice: Valeant Pharmaceuticals International, Inc.; Analysis to Aid Public Comment; Proposed Consent Agreement (November 15, 2016) Comments 1.Christina L Tobin - Nov 9, 2016 #00004 Comments From Members of Congress
Comments